Click image to view it in full size

This Frost & Sullivan study analyzes the global interventional X-ray (IXR) market. The research scope includes market trends (utilization of conventional and emerging clinical applications, growth indicators, factors influencing RoI, critical unmet needs and potential game-changing strategies, growth opportunities for fixed IXR and surgical C-arm systems, technology trends driving IXR growth, and future growth prospects); competitive structure; market metrics; market share; revenue and unit forecast; and growth strategies.

Over the past 20 years, IXR equipment has been widely adopted by hospitals across the world, especially in radiology and cardiology. It is a mature and highly penetrated market and presents replacement potential in the United States, Australia, Japan, and western Europe; however, it is a growing market in eastern Europe and most Asian countries. The US market is expected to witness fairly low growth rates in the low single-digit ranges for both high-end and low-end IXR. The western European market is witnessing a slow growth rate in high-end systems and moderate growth in low-end IXR. Approximately 50% of high-end systems have been in use for more than 8 years, and they are due for replacement. Advancements in mobile C-arms are attracting end users, especially in ambulatory settings and emergency and sports medicine. Moreover, with the advent of private hospitals and a favorable reimbursement scenario, demand for patient safety and high-quality technologies, reduced hospitalization rates, and a reduction in overall healthcare costs have become important trends.